First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: The recent contract with a major pharmaceutical company and the expansion of production capacity are likely to enhance revenue growth, improving investor sentiment.
1Narmada Gelatines has secured a long-term contract with a major pharmaceutical company, expected to increase revenue by 15% annually over the next three years.
2The company is investing in a new production facility that will enhance capacity by 25% and reduce per-unit costs by 10%.
3A recent surge in demand for collagen peptides in health supplements is expected to drive a 20% increase in that segment's revenue.
4Growing demand for collagen in health and wellness products
5Shift towards sustainable and plant-based food ingredients
6Fluctuations in raw material prices, particularly pork and bovine hides
7Changes in demand from the food and pharmaceutical sectors
8Regulatory changes affecting food safety and pharmaceutical standards